JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps

The treatment landscape for alopecia areata is shifting with the recent FDA approval of two JAK inhibitors and a robust development pipeline. Join us for this multiactivity program to hear the latest insights about pathophysiology, diagnosis, management, and much more from renowned dermatology experts.

Share

Program Content

Activities

Slides on JAK Inhibitors for Alopecia Areata
JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2023

Slides on JAK Inhibitors for Alopecia Areata
Slideset on JAK Inhibitor Therapy for Alopecia Areata
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 10, 2023

Activities

JAK inhibitors in AA Commentary
Key Considerations for Using JAK Inhibitors for Alopecia Areata
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 10, 2023

Expires: October 09, 2024

Q&A on JAK Inhibitors in AA
Expert Dermatologists Respond to Questions About JAK Inhibitor Therapy for Alopecia Areata
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Activities

JAK Inhibitors for Alopecia Areata
JAK Inhibitor Therapy for Alopecia Areata: Expert Guidance to Fill in the Gaps
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 10, 2023

Expires: October 09, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

National Alopecia Areata Foundation

ProCE Banner

In partnership with the National Alopecia Areata Foundation.